Cardiomyopathies

  • A. Ross Lorimer
  • W. Stewart Hillis
Part of the Treatment in Clinical Medicine book series (TC MEDICINE)

Abstract

Cardiomyopathies can be defined as disorders of cardiac muscle of unknown cause. This group of cardiac disorders has been the subject of intensive investigation in the last decade and much has been learned with regard to their pathophysiology. Unfortunately the aetiology remains essentially unknown and treatment is often empirical and relatively ineffective. These conditions must be distinguished from disorders which affect the heart muscle and other organs as part of a systemic disease, for which specific forms of therapy are in some instances indicated (Table 14.1).

Keywords

Cardiol Propranolol Digoxin Verapamil Aldosterone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braunwald E, Ebert PA (1962) Haemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 10: 389–395CrossRefGoogle Scholar
  2. Caves PK, Stinson EB, Billingham M, Shumway N (1973) Percutaneous transvenous endomyocardial biopsy in human heart recipients. Ann Thorac Surg 16: 325–336PubMedCrossRefGoogle Scholar
  3. Chew CC, Ziady GM, Raphael MJ, Oakley CM (1975) The functional defect in amyloid heart disease. The stiff heart syndrome. Am J Cardiol 36: 438–442PubMedCrossRefGoogle Scholar
  4. Davies MJ, Brooksby IAB, Jenkins BS, Cankovic-Darracoft S, Swanton RH, Coltart DJ, Webb-Peploe MM (1977) Left ventricular endomyocardial biopsy. II. The value of light microscopy. Cathet Cardiovasc Diagn 3: 123–130PubMedCrossRefGoogle Scholar
  5. Doi YL, McKenna WJ, Gehrke J, Oakley CM, Goodwin JF (1980) M-mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol 45: 6–14PubMedCrossRefGoogle Scholar
  6. Eckstein RE, Mempel W, Boite HD (1982) Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation 65: 1224–1229PubMedCrossRefGoogle Scholar
  7. Fuster V, Gersh BJ, Giuliani ER et al. (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525–531PubMedCrossRefGoogle Scholar
  8. Gau GT, Goodwin JF, Oakley CM, Olsen EGJ, Rahmjoola SH, Raphael MJ, Steiner RE (1972) Q waves and coronary arteriography in cardiomyopathy. Br Heart J 34: 1034–1041PubMedCrossRefGoogle Scholar
  9. Goodwin JF (1979) Cardiomyopathy: an interface between fundamental and clinical cardiology. Proceedings of the VIII World Congress of Cardiology. Excerpta Medica, Amsterdam, pp 103–116Google Scholar
  10. Goodwin JF (1980) An appreciation of hypertrophic cardiomyopathy. Am J Med 68: 797–800CrossRefGoogle Scholar
  11. Goodwin JF (1982) The frontiers of cardiomyopathy. Br Heart J 48: 1–18PubMedCrossRefGoogle Scholar
  12. Goodwin JF, Krikler DM (1976) Arrhythmias as a cause of sudden death in hypertrophic cardiomyopathy. Lancet II: 937–940CrossRefGoogle Scholar
  13. Goodwin JF, Hollman GH, Gordon H, Bishop A (1961) Clinical aspects of cardiomyopathy. Br Med J I: 69–79CrossRefGoogle Scholar
  14. Henry WL, Clark CE, Glancy DL, Epstein SE (1973) Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertophic subaortic stenosis. N Engl J Med 288: 989–993PubMedCrossRefGoogle Scholar
  15. Kaltenbach M, Hopf R, Kober G, Bussmann WD, Keller M, Petersen Y (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 42: 35–42PubMedCrossRefGoogle Scholar
  16. Lorell B, Paulus WJ, Grossman W et al. (1982) Modification of abnormal left ventricular diastolic properties in patients by nifedipine with hypertrophic cardiomyopathy. Circulation 65: 499–507PubMedCrossRefGoogle Scholar
  17. Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE (1978) “Malignant” hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 41: 1133–1140PubMedCrossRefGoogle Scholar
  18. McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta-adrenergic blocking therapy. Am J Cardiol 45: 1–5PubMedCrossRefGoogle Scholar
  19. McKenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF (1981) Arrhythmia in hypertophic cardiomyopathy. 1. Influence on prognosis. Br Heart J 46: 168–172PubMedCrossRefGoogle Scholar
  20. Morrow AG, Reitz BA, Epstein SE et al. (1975) Operative treatment in hypertrophic subaortic stenosis. Techniques and the results of pre- and post-operative assessments in 83 patients. Circulation 52: 88–102PubMedGoogle Scholar
  21. Murgo JP, Alter BR, Dorethy JF, Altobelli SA (1980) Dynamics of left ventricular ejection in obstructive and non-obstructive hypertrophic cardiomyopathy. J Clin Invest 66: 1369–1382PubMedCrossRefGoogle Scholar
  22. Nippoldt TB, Edwards WD, Holmes DR et al. (1982) Right ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients. Mayo Clin Proc 57: 607–618Google Scholar
  23. Peters TJ, Wells G, Oakley CM, Brooksby IAB, Jenkins BS, Webb-Peploe MM, Coltart DJ (1977) Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. Br Heart J 39: 1333–1339PubMedCrossRefGoogle Scholar
  24. Polliok C (1982) Haemodynamie and clinical improvement after disopyramide. N Engl J Med 307: 997–999CrossRefGoogle Scholar
  25. Regan TJ, Levinson GE, Oldewurtal HA, et al. (1969) Ventricular function in noncardiacs with alcoholic fatty liver. Role of ethanol in the production of cardiomyopathy. J Clin Invest 48: 397–400PubMedCrossRefGoogle Scholar
  26. Roberts WC, Ferrans VJ (1978) Pathology of myocardial diseases. In: Hurst JW, Logue RB, Schiant RC, Wenger NK (eds) The heart, arteries and veins, 4th edn. McGraw-Hill, New York, pp 1516–1521Google Scholar
  27. Rosing DR, Kent KM, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 60: 1208–1213PubMedGoogle Scholar
  28. Savage DD, Seides SF, Maron BJ, Myers DJ, Epstein SE (1979) Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertophic cardiomyopathy. Circulation 59: 866–875PubMedGoogle Scholar
  29. Shabetai R (1983) Cardiomyopathy: How far have we come in 25 years? How far yet to go? J Am Coll Cardiol 1: 252–263PubMedCrossRefGoogle Scholar
  30. Simon AL, Ross J Jr, Gault JH (1967) Angiographic anatomy of the left ventricle and mitral valve in idiopathic hypertophic subaortic stenosis. Circulation 36: 852–867PubMedGoogle Scholar
  31. Swedberg K, Hjalmerson A, Waagstein F, Wallentin I (1980) Beneficial effects of longterm betablockade in congestive cardiomyopathy. Br Heart J 44: 117–133PubMedCrossRefGoogle Scholar
  32. Tyberg TI, Goodyer AVN, Hurst JW et al. (1981) Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis. Am J Cardiol 47: 791–796PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • A. Ross Lorimer
    • 1
  • W. Stewart Hillis
    • 2
  1. 1.Royal InfirmaryGlasgowScotland, UK
  2. 2.Stobhill General HospitalGlasgowScotland, UK

Personalised recommendations